SeqOne Genomics

France - Montpellier, Occitanie

• 24/01/2022
• Series A
• $22,600,000

Providing genomic analysis to everybody.

SeqOne is a company focused on developing state-of-the-art genomic analysis tools for clinical applications in the fields of cancer and rare disease. The company's vision is to develop a genomic analysis system that dramatically reduces the cost and resources needed to provide accurate genomic analysis. Our aim is to make genetic testing easier and more accessible in order to accelerate the adoption of personalized medicine.

SeqOne’s platform makes it possible to efficiently analyze "high resolution" next generation sequencing (NGS) data, providing a complete list of all genetic variants and prioritizing them in order of relevance. The platform uses a proprietary machine learning-based variant prioritization engine designed to identify variants that are medically relevant to each specific patient.

SeqOne bioinformatics (genomic analysis algorithms) are organized by applications, which provide accurate answers to medical questions that influence patient treatment, in both constitutional and somatic pathologies.
SeqOne offers applications to analyze a single-patient or an entire family to diagnose hereditary family disorders, detecting complex events such as large structural modifications or transposable elements. In the field of somatic cancer, applications can analyze tumor-only, compare healthy versus tumoral samples, or hematological cancers identifying relevant variants, such as somatic CNV, TMB, MSI, or fusion genes, as well as suggest therapeutic options.

The SeqOne platform addresses the operational challenges of performing NGS analysis at scale, including secure data storage, management of process quality, and traceability needed for certification. We adopt a unique approach to process quality control that addresses ongoing process monitoring as well as changes to upstream lab procedures.

Related People

Nicolas PhilippeFounder

France - Montpellier, Occitanie,

My passion for genomic medicine and precision medicine began in 2007 when the field of gene sequencing was making its first steps on solid ground. I found myself working on large and complex projects of high throughput sequencing (NGS). My passion led me my post-doctoral fellowship in bioinformatics and to developing specialized tools for tackling biomedical issues, with a focus on the discovery of genomic biomarkers.

Founding SeqOne in 2017, an innovative startup spearheading the field of genomics, was the natural progression of the mission I set out on: to deliver genetic tests to all.

SeqOne is supported and funded by BIC (Business Innovation Center), AxLR - SATT (Société d'Accélération du Transfert de Technologies ) and LRI (Lanquedoc Roussillon Incubation) and is the recipient of several honors and awards in innovation, design and business.

LinkedIn https://www.linkedin.com/in/nicolas-philippe-/